Integrating HIV care and treatment into tuberculosis clinics in Lusaka, Zambia: results from a before-after quasi-experimental study

Table 6 Estimated effect of the integrated TB/HIV treatment and care intervention, and other covariates, on successful TB treatment (cure or completion) (N = 284)

Characteristic	Unadjusted		p-value	Adjusted^a		p-value
Characteristic	OR	95% CI	p-value	OR	95% CI	p-value
Integration Intervention
After	1.77	(0.99, 3.15)	0.05	2.02	(1.11, 3.67)	0.02
Before	1.00
Sex
Female	1.10	(0.61, 1.98)	0.75	1.16	(0.64, 2.13)	0.62
Male	1.00
Age
≥ 35 years	1.05	(0.59, 1.87)	0.87	1.08	(0.60, 1.95)	0.81
< 35 years	1.00
Clinic
Clinic B	0.57	(0.32, 1.02)	0.06	0.50	(0.27, 0.92)	0.03
Clinic A	1.00
TB Site
Extra-pulmonary	0.77	(0.35, 1.69)	0.52	0.82	(0.37, 1.82)	0.62
Pulmonary	1.00
TB Registration Type^b
Treatment after Default, Failure OR Relapse	0.94	(0.42, 2.10)	0.89	0.99	(0.43, 2.28)	0.98
New	1.00
ART started within 8 weeks of TB treatment
Yes	1.30	(0.72, 2.32)	0.38	1.16	(0.63, 2.13)	0.63
No	1.00

OR Odds ratio
^aOR estimated by logistic regression modelling, adjusting for remaining variables presented in the table
^bRelapse, treatment after default, and failure were collapsed into one category due to collinearity in the model

ISSN: 1471-2334